Marie-Pierre L.
- Country
- France
- Department
- Hematology
Research Overview
- Efficacy of Venetoclax Plus Cytarabine Versus Idarubicin Plus Cytarabine in Post-Remission Therapy for Elderly Patients with Acute Myeloid Leukemia
- Phase 3 Study of Oral Arsenic Trioxide QTX-2101 in Newly Diagnosed Low-Risk Acute Promyelocytic Leukemia
- Immunogenicity and safety of bivalent recombinant RSV preF vaccine vs AS01E‑adjuvanted RSV preF vaccine in lung and allogeneic HSCT recipients: Phase 2
Data & Insights
Has run more than one trial at 39 of 158 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the treatment of acute myeloid leukemia, with particular emphasis on developing therapeutic strategies for newly diagnosed patients. Their research encompasses comprehensive approaches combining targeted therapies with standard treatment protocols.
- First-line AML Treatment
- Combination Therapy Approaches
- Maintenance Treatment Strategies
The investigator's work involves evaluating novel therapeutic agents in conjunction with conventional chemotherapy regimens.
Molecular Targeted Therapies
The investigator focuses on advancing treatment options for patients with specific molecular profiles, particularly those with FLT3-ITD negative acute myeloid leukemia. Their research explores innovative therapeutic combinations to improve patient outcomes.
- Targeted Drug Development
- Molecular Profiling
- Treatment Response Assessment
Their work examines the integration of targeted agents into established treatment protocols.
Clinical Outcomes Research
The investigator's research concentrates on evaluating overall survival outcomes in hematologic malignancies. Their work encompasses the assessment of treatment efficacy through controlled clinical studies comparing various therapeutic approaches.
- Survival Analysis
- Treatment Optimization
- Long-term Patient Monitoring
Their studies include extended follow-up periods to assess long-term treatment effects.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.